Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.

The secretion of glucagon by pancreatic alpha-cells plays a critical role in the regulation of glycaemia. This hormone counteracts hypoglycaemia and opposes insulin actions by stimulating hepatic glucose synthesis and mobilization, thereby increasing blood glucose concentrations. During the last decade, knowledge of alpha-cell physiology has greatly improved, especially concerning molecular and cellular mechanisms. In this review, we have addressed recent findings on alpha-cell physiology and the regulation of ion channels, electrical activity, calcium signals and glucagon release. Our focus in this review has been the multiple control levels that modulate glucagon secretion from glucose and nutrients to paracrine and neural inputs. Additionally, we have described the glucagon actions on glycaemia and energy metabolism, and discussed their involvement in the pathophysiology of diabetes. Finally, some of the present approaches for diabetes therapy related to alpha-cell function are also discussed in this review. A better understanding of the alpha-cell physiology is necessary for an integral comprehension of the regulation of glucose homeostasis and the development of diabetes.

[1]  M. Köhler,et al.  Glutamate is a positive autocrine signal for glucagon release. , 2008, Cell metabolism.

[2]  E. Carneiro,et al.  Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors. , 2008, American journal of physiology. Endocrinology and metabolism.

[3]  X. Li,et al.  Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice. , 2008, Clinical science.

[4]  P. MacDonald,et al.  Investigation of Transport Mechanisms and Regulation of Intracellular Zn2+ in Pancreatic α-Cells* , 2008, Journal of Biological Chemistry.

[5]  P. Gilon,et al.  The GluCre‐ROSA26EYFP mouse: A new model for easy identification of living pancreatic α‐cells , 2007 .

[6]  R. Robertson,et al.  Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats. , 2007, Endocrinology.

[7]  L. Eliasson,et al.  A KATP Channel-Dependent Pathway within α Cells Regulates Glucagon Release from Both Rodent and Human Islets of Langerhans , 2007, PLoS biology.

[8]  F. Sundler,et al.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet , 2007, Diabetologia.

[9]  J. Gerich,et al.  The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. , 2007, Endocrine reviews.

[10]  J. Bryan,et al.  Zinc, Not Insulin, Regulates the Rat α-Cell Response to Hypoglycemia In Vivo , 2007, Diabetes.

[11]  K. Hermansen,et al.  Fatty acid‐induced effect on glucagon secretion is mediated via fatty acid oxidation , 2007, Diabetes/metabolism research and reviews.

[12]  J. Rosenstock,et al.  Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes , 2007, Diabetes Care.

[13]  M. Ravier,et al.  Glucose-Dependent Regulation of γ-Aminobutyric Acid (GABAA) Receptor Expression in Mouse Pancreatic Islet α-Cells , 2007, Diabetes.

[14]  B. Wiedenmann,et al.  Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. , 2007, The Journal of clinical endocrinology and metabolism.

[15]  J. Gromada,et al.  α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains. , 2007, Endocrine reviews.

[16]  A. Salehi,et al.  Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells , 2007, Diabetologia.

[17]  A. Young,et al.  Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187 , 2006, Regulatory Peptides.

[18]  J. Holst,et al.  Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice , 2006, Diabetes.

[19]  Roy G. Smith,et al.  Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist. , 2006, Endocrinology.

[20]  J. E. Manning Fox,et al.  Oscillatory membrane potential response to glucose in islet beta-cells: a comparison of islet-cell electrical activity in mouse and rat. , 2006, Endocrinology.

[21]  Paloma Alonso-Magdalena,et al.  Glucose Induces Opposite Intracellular Ca2+ Concentration Oscillatory Patterns in Identified α- and β-Cells Within Intact Human Islets of Langerhans , 2006, Diabetes.

[22]  A. Salehi,et al.  Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptor inhibition. , 2006, Endocrinology.

[23]  N. Diamant,et al.  Insulin regulates islet alpha-cell function by reducing KATP channel sensitivity to adenosine 5'-triphosphate inhibition. , 2006, Endocrinology.

[24]  M. Eledrisi,et al.  Overview of the diagnosis and management of diabetic ketoacidosis. , 2006, The American journal of the medical sciences.

[25]  B. Soria,et al.  Different Metabolic Responses in α-, β-, and δ-Cells of the Islet of Langerhans Monitored by Redox Confocal Microscopy , 2006 .

[26]  C. Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Bryan,et al.  Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement. , 2005, Endocrinology.

[28]  N. Diamant,et al.  Electrophysiological characterization of pancreatic islet cells in the mouse insulin promoter-green fluorescent protein mouse. , 2005, Endocrinology.

[29]  S. Theander,et al.  Glucose Stimulates Glucagon Release in Single Rat α-Cells by Mechanisms that Mirror the Stimulus-Secretion Coupling in β-Cells , 2005 .

[30]  Y. Nie,et al.  Glucose Dependence of the Regulated Secretory Pathway in αTC1-6 Cells , 2005 .

[31]  K. Hermansen,et al.  The short-term effect of fatty acids on glucagon secretion is influenced by their chain length, spatial configuration, and degree of unsaturation: studies in vitro. , 2005, Metabolism: clinical and experimental.

[32]  D. Piston,et al.  Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor. , 2005, American journal of physiology. Endocrinology and metabolism.

[33]  Catherine B. Chan,et al.  Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells* , 2005, Journal of Biological Chemistry.

[34]  J. Foley,et al.  Alpha cell function in health and disease: influence of glucagon-like peptide-1 , 2005, Diabetologia.

[35]  M. Ravier,et al.  Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic α-Cells , 2005 .

[36]  S. Theander,et al.  β-Cell Secretory Products Activate α-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release , 2005 .

[37]  Alvin C. Powers,et al.  Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  M. Weiergräber,et al.  The ablation of the Ca(v)2.3/E-type voltage-gated Ca2+ channel causes a mild phenotype despite an altered glucose induced glucagon response in isolated islets of Langerhans. , 2005, European journal of pharmacology.

[39]  D. Steiner,et al.  Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon. , 2005, Endocrinology.

[40]  Yazhou Li,et al.  β-Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon-Like Peptide-1 , 2005 .

[41]  Xiaosong Ma,et al.  ATP-Sensitive K+ Channel–Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1−/− Mouse α-Cells , 2004 .

[42]  D. Moller,et al.  A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. , 2004, Diabetes.

[43]  J. Schölmerich,et al.  Stimulatory short-term effects of free fatty acids on glucagon secretion at low to normal glucose concentrations. , 2004, Metabolism: clinical and experimental.

[44]  P. Rorsman,et al.  Palmitate stimulation of glucagon secretion in mouse pancreatic alpha-cells results from activation of L-type calcium channels and elevation of cytoplasmic calcium. , 2004, Diabetes.

[45]  J. Fenyk-Melody,et al.  Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. , 2004, European journal of pharmacology.

[46]  Dennis D. Kim,et al.  Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia. , 2004, Diabetes.

[47]  J. Gromada,et al.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. , 2004, The Journal of clinical investigation.

[48]  P. Rorsman,et al.  Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. , 2004, Diabetes.

[49]  Y. Moriyama,et al.  Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans. , 2004, Diabetes.

[50]  E. Vieira,et al.  A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic alpha-cell. , 2004, Cell calcium.

[51]  B. Monia,et al.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. , 2004, Diabetes.

[52]  Y. Moriyama,et al.  Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in αTC6 Cells, Mouse Clonal α-Cells, and α-Cells of Islets of Langerhans , 2003 .

[53]  P. Meda,et al.  On-line analysis of gap junctions reveals more efficient electrical than dye coupling between islet cells. , 2003, American journal of physiology. Endocrinology and metabolism.

[54]  C. Wollheim,et al.  Islet β-cell secretion determines glucagon release from neighbouring α-cells , 2003, Nature Cell Biology.

[55]  P. Westermark,et al.  Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets , 2003, Regulatory Peptides.

[56]  D. Drucker,et al.  International Union of Pharmacology. XXXV. The Glucagon Receptor Family , 2003, Pharmacological Reviews.

[57]  J. Holst,et al.  Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Yamada,et al.  Secretory Granule-mediated Co-secretion ofl-Glutamate and Glucagon Triggers Glutamatergic Signal Transmission in Islets of Langerhans* , 2003, The Journal of Biological Chemistry.

[59]  A. Shapiro,et al.  Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. , 2002, Diabetes.

[60]  M. Stumvoll,et al.  The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. , 2002, Diabetes.

[61]  L. Cynober.  Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. , 2002, Nutrition.

[62]  P. Cryer,et al.  Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.

[63]  J. Holst,et al.  Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. , 2002, The Journal of clinical endocrinology and metabolism.

[64]  J. Sturis,et al.  Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. , 2002, Diabetes.

[65]  J. McArdle,et al.  Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. , 2001, Diabetes.

[66]  K. Petersen,et al.  Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans , 2001, Diabetologia.

[67]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[68]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[69]  P. Rorsman,et al.  Somatostatin inhibits exocytosis in rat pancreatic α‐cells by Gi2‐dependent activation of calcineurin and depriming of secretory granules , 2001, The Journal of physiology.

[70]  L. Orci,et al.  Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice* , 2001, The Journal of Biological Chemistry.

[71]  M. Jensen,et al.  Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. , 2001, The Journal of clinical endocrinology and metabolism.

[72]  Jochen Roeper,et al.  ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis , 2001, Nature Neuroscience.

[73]  M. A. Chastain.  The Glucagonoma Syndrome: A Review of its Features and Discussion of New Perspectives , 2001, The American journal of the medical sciences.

[74]  G. Rutter,et al.  Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. , 2001, Diabetes.

[75]  J. Gromada,et al.  Phentolamine Inhibits Exocytosis of Glucagon by Gi2 Protein-dependent Activation of Calcineurin in Rat Pancreatic α-Cells* , 2001, The Journal of Biological Chemistry.

[76]  B. Ahrén,et al.  Differential Effects of Glucagon-like Peptide-1 (7-36)Amide Versus Cholecystokinin on Arginine-Induced Islet Hormone Release In Vivo and In Vitro , 2001, Pancreas.

[77]  R. Rizza,et al.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[78]  Xia Li,et al.  Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[79]  L. Eliasson,et al.  Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. , 2000, Diabetes.

[80]  E. Ferrannini,et al.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. , 2000, Diabetes.

[81]  B. Ahrén,et al.  Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. , 2000, Diabetes care.

[82]  B. Ahrén.  Autonomic regulation of islet hormone secretion – Implications for health and disease , 2000, Diabetologia.

[83]  P. Rorsman,et al.  Voltage‐gated and resting membrane currents recorded from B‐cells in intact mouse pancreatic islets , 1999, The Journal of physiology.

[84]  B. Soria,et al.  Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. , 1999, Diabetes.

[85]  A. Ktorza,et al.  Chronic Exposure to High Glucose Concentrations Increases Proglucagon Messenger Ribonucleic Acid Levels and Glucagon Release from InR1G9 Cells1. , 1999, Endocrinology.

[86]  N. Westergaard,et al.  Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol. , 1999, The Biochemical journal.

[87]  U. Adamson,et al.  Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[88]  P. Rorsman,et al.  Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells , 1999, Pflügers Archiv.

[89]  R. Rizza,et al.  Impact of lack of suppression of glucagon on glucose tolerance in humans. , 1999, American journal of physiology. Endocrinology and metabolism.

[90]  H. Motoshima,et al.  Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells. , 1999, Diabetes research and clinical practice.

[91]  Angel Nadal,et al.  Homologous and heterologous asynchronicity between identified α‐, β‐ and δ‐cells within intact islets of Langerhans in the mouse , 1999 .

[92]  Y. Horio,et al.  Somatostatin induces hyperpolarization in pancreatic islet α cells by activating a G protein‐gated K+ channel , 1999, FEBS letters.

[93]  D. Pipeleers,et al.  The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets* , 1998, The Journal of Biological Chemistry.

[94]  H. Gaskins,et al.  Histidine Availability Alters Glucagon Gene Expression in Murine αTC6 Cells , 1998 .

[95]  G. Waeber,et al.  Fatty Acids Decrease IDX-1 Expression in Rat Pancreatic Islets and Reduce GLUT2, Glucokinase, Insulin, and Somatostatin Levels* , 1997, The Journal of Biological Chemistry.

[96]  P. Rorsman,et al.  Adrenaline Stimulates Glucagon Secretion in Pancreatic A-Cells by Increasing the Ca2+ Current and the Number of Granules Close to the L-Type Ca2+ Channels , 1997, The Journal of general physiology.

[97]  M. Prentki,et al.  Metabolic Fate of Glucose in Purified Islet Cells , 1997, The Journal of Biological Chemistry.

[98]  O. Vuolteenaho,et al.  Immunohistochemical Localization of Somatostatin Receptor SST2A in the Rat Pancreas. , 1997, Endocrinology.

[99]  P. Rorsman,et al.  Glucagon-Like Peptide I and Glucose-Dependent Insulinotropic Polypeptide Stimulate Ca2+-Induced Secretion in Rat α-Cells by a Protein Kinase A–Mediated Mechanism , 1997, Diabetes.

[100]  A. Berts,et al.  Cytoplasmic Ca2+ in glucagon-producing pancreatic α-cells exposed to carbachol and agents affecting Na+ fluxes , 1997, Endocrine.

[101]  O. Larsson,et al.  Imidazoline Compounds Stimulate Insulin Release by Inhibition of KATP Channels and Interaction With the Exocytotic Machinery , 1996, Diabetes.

[102]  O. Madsen,et al.  The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[103]  L. Orci,et al.  Adequate connexin-mediated coupling is required for proper insulin production , 1995, The Journal of cell biology.

[104]  L. Olson,et al.  Somatostatin coordinately regulates glucagon gene expression and exocytosis in HIT-T15 cells. , 1995, The Journal of clinical investigation.

[105]  I. Kurland,et al.  Covalent control of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase: Insights into autoregulation of a bifunctional enzyme , 1995, Protein science : a publication of the Protein Society.

[106]  T. Iwanaga,et al.  Expression and role of ionotropic glutamate receptors in pancreatic islet cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  D. Pipeleers,et al.  Differences in Glucose Transporter Gene Expression between Rat Pancreatic α- and β-Cells Are Correlated to Differences in Glucose Transport but Not in Glucose Utilization (*) , 1995, The Journal of Biological Chemistry.

[108]  S. Dinneen,et al.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM , 1995, Diabetologia.

[109]  J. Philippe,et al.  Islet-specific Proteins Interact with the Insulin-response Element of the Glucagon Gene (*) , 1995, The Journal of Biological Chemistry.

[110]  T. Schwartz,et al.  Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. , 1994, The Journal of biological chemistry.

[111]  P. Kern,et al.  Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. , 1994, Journal of lipid research.

[112]  G. Shulman,et al.  Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. , 1994, The Journal of clinical investigation.

[113]  M. J. MacDonald,et al.  Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. , 1994, The Journal of biological chemistry.

[114]  M. G. Carlson,et al.  Regulation of free fatty acid metabolism by glucagon. , 1993, The Journal of clinical endocrinology and metabolism.

[115]  J. Bockaert,et al.  Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. , 1993, European journal of pharmacology.

[116]  L. Bankir,et al.  Effects of glucagon on glomerular filtration rate and urea and water excretion. , 1992, The American journal of physiology.

[117]  J. Girard,et al.  Regulation of fatty‐acid metabolism by pancreatic hormones in cultured human hepatocytes , 1991, Hepatology.

[118]  T. Ogihara,et al.  Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36 amide) without affect on mRNA level in isolated rat islets. , 1990, Biochemical and biophysical research communications.

[119]  P. Rorsman,et al.  Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels , 1989, Nature.

[120]  D. Scharp,et al.  Three-Dimensional Imaging of Intact Isolated Islets of Langerhans With Confocal Microscopy , 1989, Diabetes.

[121]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.

[122]  M. Derde,et al.  Sensitivity of rat pancreatic A and B cells to somatostatin , 1989, Diabetologia.

[123]  B. Ahrén,et al.  Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon. , 1987, Endocrinology.

[124]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[125]  V. Grill,et al.  Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect , 1986, Diabetologia.

[126]  L. Orci,et al.  Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.

[127]  V. Hruby,et al.  Activation of two signal-transduction systems in hepatocytes by glucagon , 1986, Nature.

[128]  E. Hooghe-Peters,et al.  Interplay of nutrients and hormones in the regulation of insulin release. , 1985, Endocrinology.

[129]  W. Malaisse,et al.  Multiple effects of leucine on glucagon, insulin, and somatostatin secretion from the perfused rat pancreas. , 1985, Endocrinology.

[130]  A. Depaoli-Roach,et al.  Control of glycogen synthase phosphorylation in isolated rat hepatocytes by epinephrine, vasopressin and glucagon. , 1984, European journal of biochemistry.

[131]  P. Cryer,et al.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine intera , 1984, The Journal of clinical investigation.

[132]  D. Pipeleers,et al.  Differences in glucose handling by pancreatic A- and B-cells. , 1983, The Journal of biological chemistry.

[133]  J. Palmer,et al.  Glucose regulation of glucagon secretion independent of B cell activity. , 1983, Metabolism: clinical and experimental.

[134]  B. Ahrén,et al.  Influences of Gastro-Intestinal Polypeptides and Glucose on Glucagon Secretion Induced by Cholinergic Stimulation , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[135]  M. Lorenzi,et al.  Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects. , 1982, The Journal of clinical endocrinology and metabolism.

[136]  G. Band,et al.  Functional activation by glucagon of glucose 6‐phosphatase and gluconeogenesis in the perfused liver of the fetal guinea pig , 1980, FEBS letters.

[137]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.

[138]  G. Ribes,et al.  Tolbutamide and glucagon secretion. , 1974, Diabetologia.

[139]  Y. Zhang,et al.  Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. , 2006, Cell metabolism.

[140]  A. Young.  Inhibition of glucagon secretion. , 2005, Advances in pharmacology.

[141]  L. Eliasson,et al.  Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors. , 2005, Molecular endocrinology.

[142]  D.,et al.  Low Level Cyclic Adenosine 3’,5’-Monophosphate Accumulation Analysis of [des-His’,des-Phe’,Glu’]Glucagon-NH, Identifies Glucagon Antagonists from Weak Partial Agonists/Antagonists* , 2001 .

[143]  J. Schaeffer,et al.  Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice. , 2000, Endocrinology.

[144]  D. Drucker,et al.  The Glucagon Receptor Family , 2000 .

[145]  P. Meda,et al.  Glucose Regulates Proinsulin and Prosomatostatin But Not Proglucagon Messenger Ribonucleic Acid Levels in Rat Pancreatic Islets1. , 2000, Endocrinology.

[146]  M. Thangaraju,et al.  Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. , 1999, Diabetes.

[147]  X. Ding,et al.  Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. , 1999, The American journal of physiology.

[148]  P. Dussoix,et al.  Insulin, but not glucose lowering corrects the hyperglucagonemia and increased proglucagon messenger ribonucleic acid levels observed in insulinopenic diabetes. , 1998, Endocrinology.

[149]  P. Rorsman,et al.  Adrenaline Stimulates Glucagon Secretion in Pancreatic A-Cells by Increasing the Ca 2 1 Current and the Number of Granules Close to the , 1997 .

[150]  É. Mezey,et al.  Erratum: Immunohistochemical localization of somatostatin receptor sst2A in the rat pancreas (Endocrinology (1997) 138 (2632-2635)) , 1997 .

[151]  B. Göke,et al.  Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells. , 1995, The American journal of physiology.

[152]  A. Ohneda,et al.  Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. , 1991, The American journal of physiology.

[153]  A. Golay,et al.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[154]  W. Blackard,et al.  Effect of lipids on glucagon secretion in man. , 1975, Metabolism: clinical and experimental.